FDA regulation of in vitro diagnostics: the changing US environment
This article was originally published in Clinica
Executive Summary
Jonathan Kahan looks at some of the creative and important initiatives relating to the regulation of in vitro diagnostics (IVDs) which have taken place at the FDA and discusses the more general changes affecting IVD regulation in the US.